Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid
dc.contributor.author | Lee, Kai-Fai | |
dc.contributor.author | Lau, Kin-Mang | |
dc.contributor.author | Ho, Shuk-Mei | |
dc.date | 2022-08-11T08:09:00.000 | |
dc.date.accessioned | 2022-08-23T16:15:01Z | |
dc.date.available | 2022-08-23T16:15:01Z | |
dc.date.issued | 2000-01-06 | |
dc.date.submitted | 2008-10-15 | |
dc.identifier.citation | Toxicol Appl Pharmacol. 1999 Dec 15;161(3):294-301. <a href="http://dx.doi.org/10.1006/taap.1999.8821 ">Link to article on publisher's site</a> | |
dc.identifier.issn | 0041-008X (Print) | |
dc.identifier.doi | 10.1006/taap.1999.8821 | |
dc.identifier.pmid | 10620487 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/34000 | |
dc.description.abstract | Two trans-acting hammerhead ribozymes (Rzs), Rz1-2 and Rz4-9, were designed and shown to be effective in cleaving rat or mouse metallothenein (MT)-I and MT-II mRNA, respectively, at position +147/148, in a sequence-specific manner. The catalytic efficiency for Rz1-2 on rat MT-I was found to be 678 M(-1)s(-1) and that for Rz4-9 on rat MT-II cRNA was found to be 372 M(-1)s(-1). An expression vector, pRz(4-9/1-2), containing both Rzs linked in tandem, was constructed and used to transfect NbE-1 cells, an immortalized ventral prostate epithelial cell line. Two stable-transfected lines, NbE-1(Rz2) and NbE-1(Rz3), expressing substantial levels of (Rz1-2/Rz4-9) and minimal levels of MT-I and MT-II transcripts were found to exhibit increased sensitivity to cadmium (Cd)-induced cytotoxicity compared to the parent line. This article is the first to report successful degradation of rodent MT mRNA in vitro and in cellulo by hammerhead Rzs. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10620487&dopt=Abstract">Link to article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1006/taap.1999.8821 | |
dc.title | Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid | |
dc.type | Journal Article | |
dc.source.journaltitle | Toxicology and applied pharmacology | |
dc.source.volume | 161 | |
dc.source.issue | 3 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/653 | |
dc.identifier.contextkey | 651123 | |
html.description.abstract | <p>Two trans-acting hammerhead ribozymes (Rzs), Rz1-2 and Rz4-9, were designed and shown to be effective in cleaving rat or mouse metallothenein (MT)-I and MT-II mRNA, respectively, at position +147/148, in a sequence-specific manner. The catalytic efficiency for Rz1-2 on rat MT-I was found to be 678 M(-1)s(-1) and that for Rz4-9 on rat MT-II cRNA was found to be 372 M(-1)s(-1). An expression vector, pRz(4-9/1-2), containing both Rzs linked in tandem, was constructed and used to transfect NbE-1 cells, an immortalized ventral prostate epithelial cell line. Two stable-transfected lines, NbE-1(Rz2) and NbE-1(Rz3), expressing substantial levels of (Rz1-2/Rz4-9) and minimal levels of MT-I and MT-II transcripts were found to exhibit increased sensitivity to cadmium (Cd)-induced cytotoxicity compared to the parent line. This article is the first to report successful degradation of rodent MT mRNA in vitro and in cellulo by hammerhead Rzs.</p> | |
dc.identifier.submissionpath | gsbs_sp/653 | |
dc.contributor.department | Department of Surgery | |
dc.contributor.department | Morningside Graduate School of Biomedical Sciences | |
dc.source.pages | 294-301 |